Biological Products, (No Diagnostic Substances) · DE · CIK 1707502
Advancing gene therapy candidates for genetic cardiac and neuromuscular diseases
Comparable business profile · signals at a glance
In the 90 days to Feb 18, 2026: 7 sold $2.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 18, 2026 | Cumbo AlexanderPresident and CEO | Sell | 16,644 | $5.82 | $97K |
| Feb 18, 2026 | Howton David TChief Operating Officer | Sell | 7,469 | $5.82 | $43K |
| Feb 18, 2026 | Tan KevinCFO & Treasurer | Sell | 5,404 | $5.82 | $31K |
| Feb 18, 2026 | Hanrahan JessieChief Regulatory Officer | Sell | 4,134 | $5.82 | $24K |
| Feb 18, 2026 | Herzich PaulChief Technology Officer | Sell | 3,616 | $5.82 | $21K |
| Feb 18, 2026 | Ganot IlanDirector | Sell | 2,658 | $5.82 | $15K |
| Feb 18, 2026 | Brooks GabrielChief Medical Officer | Sell | 0 | $5.82 | $0 |
| Feb 4, 2026 | Cumbo AlexanderPresident and CEO | Sell | 48,913 | $6.44 | $315K |
| Feb 4, 2026 | Howton David TChief Operating Officer | Sell | 18,894 | $6.44 | $122K |
| Feb 4, 2026 | Tan KevinCFO & Treasurer | Sell | 14,783 | $6.44 | $95K |
| Feb 4, 2026 | Brooks GabrielChief Medical Officer | Sell | 12,616 | $6.44 | $81K |
| Feb 4, 2026 | Hanrahan JessieChief Regulatory Officer | Sell | 12,348 | $6.44 | $80K |
| Feb 4, 2026 | Herzich PaulChief Technology Officer | Sell | 10,905 | $6.44 | $70K |
| Feb 4, 2026 | Ganot IlanDirector | Sell | 7,205 | $6.44 | $46K |
| Feb 2, 2026 | Cumbo AlexanderPresident and CEO | Sell | 80,258 | $6.44 | $517K |
| Feb 2, 2026 | Howton David TChief Operating Officer | Sell | 37,771 | $6.44 | $243K |
| Feb 2, 2026 | Brooks GabrielChief Medical Officer | Sell | 28,335 | $6.44 | $182K |
| Feb 2, 2026 | Tan KevinCFO & Treasurer | Sell | 26,837 | $6.44 | $173K |
| Feb 2, 2026 | Hanrahan JessieChief Regulatory Officer | Sell | 26,535 | $6.44 | $171K |
| Feb 2, 2026 | Herzich PaulChief Technology Officer | Sell | 26,250 | $6.44 | $169K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.